The DOI matches its Crossref record; 31 of the 39 references it cites were found in a registry or an index; 19 of the 36 sources its claims cite were checked for support.
Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis
Open accessAbstract
Epilepsy is one of the most prevalent chronic neurological disorders worldwide, affecting approximately 70 million people globally and imposing substantial burdens on patients, families, and healthcare systems. Its multifaceted treatment landscape spanning antiepileptic drug (AED) therapy, epilepsy surgery, ketogenic dietary therapy, and neuromodulation makes accurate health information critical for patient decision-making and treatment adherence. Short-video platforms such as TikTok (Douyin) and Bilibili have emerged as primary channels through which the public accesses health-related content, yet the quality and reliability of epilepsy-related content on these platforms remain largely unexamined. A cross-sectional content analysis was conducted. We systematically retrieved videos via keyword search on TikTok (Douyin) and Bilibili, using the terms "dianxian" (epilepsy) and "jingfeng" (seizure/convulsion). For each platform, we collected the top 100 unique videos ranked by the platform's default relevance algorithm, with duplicate results from the two search terms removed. After applying pre-specified inclusion and exclusion criteria, 182 videos were included in the final analysis. Two physicians independently assessed the videos using a multi-instrument framework with clear applicable boundaries: Global Quality Score (GQS, for overall educational quality across all content types), modified DISCERN (mDISCERN, exclusively for treatment information reliability), JAMA benchmark criteria (for source transparency, not direct clinical accuracy), and a novel Treatment Misinformation Risk Scale (TMRS, specifically for epilepsy treatment-related content). Inter-rater reliability was assessed using the intraclass correlation coefficient (ICC). Engagement metrics and uploader characteristics were also recorded, with sensitivity analyses performed to control for confounding from uneven content theme distribution between platforms. A total of 182 videos were analyzed (96 from TikTok, 86 from Bilibili). The overall educational quality was suboptimal (mean GQS: 2.65 ± 0.93; mDISCERN: 2.12 ± 0.89 for treatment-containing videos). Bilibili videos demonstrated significantly higher performance across all instruments: overall educational quality (GQS: 3.11 ± 0.87 vs. 2.24 ± 0.84, P < 0.001), treatment information reliability (mDISCERN: 2.56 ± 0.81 vs. 1.74 ± 0.76, P < 0.001), and source transparency (JAMA: 2.18 ± 0.72 vs. 1.42 ± 0.68, P < 0.001). The mean normalized TMRS score was 1.15 ± 0.62, with TikTok showing significantly higher treatment misinformation risk (1.41 ± 0.54) than Bilibili (0.86 ± 0.53, P < 0.001). TMRS scores were positively correlated with likes (rho = 0.46, P < 0.001), shares (rho = 0.43, P < 0.001), and comments (rho = 0.39, P < 0.001), while quality scores showed no significant correlation with engagement. Sensitivity analyses confirmed that the observed platform differences were not confounded by differences in content theme distribution. Epilepsy-related content on China's major short-video platforms is of concerningly poor quality, with treatment misinformation receiving disproportionately higher user engagement. These findings highlight the urgent need for collaborative efforts among neurologists, platform operators, and health authorities to improve the quality of epilepsy health information in the digital environment.
Overview
CoChat Summary
## TL;DR
This cross-sectional analysis of 182 epilepsy-related videos on TikTok (Douyin) and Bilibili found generally low educational quality and a moderate overall treatment misinformation risk, with Bilibili outperforming TikTok on quality and reliability. Treatment misinformation risk was positively correlated with engagement, suggesting a “quality-engagement paradox,” but the study design cannot establish causality.
## Key findings
- Of 200 retrieved videos, 182 met inclusion criteria: 96 from TikTok and 86 from Bilibili.
- Overall video quality was suboptimal: mean GQS was 2.65 ± 0.93 across all videos; among treatment-containing videos, mean mDISCERN was 2.12 ± 0.89.
- Bilibili videos scored higher than TikTok on all main quality/reliability measures: GQS 3.11 ± 0.87 vs 2.24 ± 0.84, mDISCERN 2.56 ± 0.81 vs 1.74 ± 0.76, and JAMA 2.18 ± 0.72 vs 1.42 ± 0.68, all P < 0.001.
- TikTok had higher treatment misinformation risk: normalized TMRS 1.41 ± 0.54 vs 0.86 ± 0.53 on Bilibili (P < 0.001). TMRS was positively correlated with likes (rho = 0.46), shares (rho = 0.43), and comments (rho = 0.39), all P < 0.001.
- In multivariable analysis, Bilibili remained independently associated with higher GQS (beta = 0.52, 95% CI 0.23 to 0.81, P < 0.001) and lower TMRS (beta = -0.31, 95% CI -0.50 to -0.12, P = 0.002).
## Methods
- Cross-sectional content analysis of publicly available short videos on TikTok (Douyin) and Bilibili, using Chinese search terms “dianxian” and “jingfeng.”
- The study searched the top 100 unique relevance-ranked videos per platform; after deduplication and screening, 182 videos remained. Searches were done in parallel on December 15–17, 2025 using new non-logged-in accounts.
- Two board-certified physicians independently rated videos using GQS, mDISCERN, JAMA, and a novel TMRS; statistical analysis used nonparametric tests, Spearman correlations, subgroup analyses, and multivariable linear regression adjusting for uploader source, duration, references, and verification status.
## Limitations
- The paper explicitly states that the cross-sectional design captures only a snapshot and cannot establish temporal sequence, direction of effects, or causality.
- Sampling was limited to actively searched, top 100 relevance-ranked videos, excluding recommendation-feed content, ultra-short/very long videos, and low-view “long-tail” content; the paper says this limits representativeness.
- Residual confounding may remain despite adjustment; the paper also notes TMRS has not been externally validated and its thresholds were exploratory rather than definitive.
- Evident from the text: the study was restricted to Chinese-language content on domestic platforms, so cross-cultural generalizability is limited.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
12 Valid · 3 Not valid · 6 Not checked · 101 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the open, user-generated nature of these platforms raises significant concerns about information quality and accuracy11,12.”
§ Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis > Introduction
What the sources say
- Partly supportedcites [11] Suarez-Lledo, V. & Alvarez-Galvez, J. Prevalence of health misinformation on social media: Systematic review. J. Med. Internet Res. 23, e17187 (2021). sourceExperimental — accuracy not yet measured
The Introduction describes social media as public tools through which users share health information and warns that misleading information can spread. The Results (Misinformation Topics and Methods) report concerns about the quality of YouTube health videos. The paper supports the general concern, but it does not specifically address short-video platforms. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [12] Madathil, K. C. et al. Healthcare information on YouTube: A systematic review. Health Informatics J. 21, 173–194 (2015). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The positive correlation between normalized TMRS scores and user engagement metrics (rho = 0.39–0.46 for likes, shares, and comments) is consistent with findings from prior research examining health misinformation across other neurological and chronic disease conditions on social media platforms27,28.”
§ Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis > Discussion > The treatment misinformation risk phenomenon
What the sources say
- Partly supportedcites [27] Yu, W. X. et al. Evaluating the Quality, Reliability, and Diagnostic Risk of ADHD Content on TikTok and Bilibili (Advance online publication, 2025). https://doi.org/10.1016/j.dhjo.2025.100xxx. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [28] Zhang, H. et al. Quality of information in osteoporosis videos on TikTok. Arch. Osteoporos. 20, 115 (2025). source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“with the scale developed based on established epilepsy clinical evidence, classification criteria, and treatment guidelines3,7,8,31,32 as well as emerging literature on health misinformation on social media”
§ Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis > Methods > Quality assessment tools The quality and reliability of the included videos were assessed using a pre-specified, multi-instrument framework, with each tool capturing a distinct and complementary dimension of video quality, and all scoring rules finalized prior to data collection to ensure consistency and reproducibility. The Global Quality Score (GQS), a widely validated 5-point Likert scale (1 = poor to 5 = excellent) originally developed to evaluate the overall educational quality of patient-facing web-based health content and subsequently validated for use in short-form video health content analyses20–24, was employed to assess the holistic educational value of each video, including the completeness of presented clinical information, logical flow of content, clinical utility for patients and caregivers, and accuracy of general epilepsy-related statements. The modified DISCERN (mDISCERN) instrument, adapted from the original DISCERN questionnaire—the gold-standard tool for evaluating the reliability of consumer health information on treatment choices25—was optimized for short-form video content in this study, using a 1–5 Likert scale to assess the reliability of treatment-related information, with core evaluation dimensions including the accuracy of descriptions of treatment benefits and risks, reference to evidence-based clinical guidelines, and absence of misleading or unsubstantiated treatment claims, and this instrument was applied exclusively to videos containing treatment-related content. The JAMA benchmark criteria, comprising four core items (authorship, attribution, currency, and conflict of interest disclosure), were used to evaluate the credibility and transparency of the content source, with scores ranging from 0 to 426. It should be noted that the JAMA benchmark criteria assess the transparency and credibility of the information source rather than the clinical accuracy of the content itself; a higher JAMA score therefore reflects greater source transparency but should not be interpreted as a direct indicator of medical accuracy[27,28,29]. Similarly, the GQS and mDISCERN evaluate overall educational quality and reliability of treatment information respectively, and may structurally disadvantage certain content types—particularly Lived Experience and Coping videos, which are not primarily designed to deliver comprehensive treatment information[29,30]. We acknowledge this as a potential source of confounding, particularly given the unequal distribution of content themes across platforms (e.g., TikTok had a higher proportion of Lived Experience content), and to partially address this, we conducted supplementary subgroup analyses stratified by content theme (see section “Subgroup analysis by content theme”). To address the primary research focus of this study, we developed the Treatment Misinformation Risk Scale (TMRS) to quantify the extent to which epilepsy-related content contains misleading treatment information, with the scale developed based on established epilepsy clinical evidence, classification criteria, and treatment guidelines3,7,8,31,32 as well as emerging literature on health misinformation on social media, and reviewed by two senior neurologists with specialized expertise in epilepsy management prior to formal application. The development of the TMRS followed a rigorous, structured process: first, a comprehensive item pool was generated based on a systematic review of common epilepsy treatment misconceptions documented in the clinical literature8,31,32 and a preliminary screening of 50 epilepsy-related videos (not included in the final sample) to identify recurring patterns of treatment misinformation; second, the initial item pool was refined through two rounds of expert review by two senior neurologists, each with more than 15 years of clinical experience in epilepsy management, who evaluated each item for clinical relevance, clarity, and comprehensiveness, with items retained only when both experts agreed on their inclusion, resulting in a perfect item-level content validity index (I-CVI = 1.0) for all three final items. The final TMRS comprises three items, each scored on a 3-point scale (0–2), yielding a total raw score range of 0–6, with the three items focusing on the accuracy of treatment claims, promotion of unproven therapies, and discouragement of evidence-based care respectively, where a score of 0 indicates low risk, 1 indicates moderate risk, and 2 indicates high risk. Specifically, for the accuracy of treatment claims item, a score of 0 indicates treatment information fully consistent with established clinical guidelines (e.g., correctly identifying valproate, levetiracetam, or lamotrigine as first-line antiepileptic drugs, AEDs), a score of 1 indicates partially inaccurate or misleading treatment claims (e.g., overstating the efficacy of a specific AED without acknowledging individual variability in treatment response), and a score of 2 indicates clearly inaccurate or clinically dangerous treatment claims (e.g., promoting abrupt discontinuation of AEDs, or claiming herbal remedies can replace prescription AEDs); for the promotion of unproven therapies item, a score of 0 indicates no promotion of unproven therapies, a score of 1 indicates mention of unproven therapies without explicit endorsement, and a score of 2 indicates active promotion of unproven therapies (e.g., specific herbal formulations, acupuncture marketed as a seizure cure, or dietary supplements) as definitive treatments for epilepsy; for the discouragement of evidence-based care item, a score of 0 indicates no discouragement of guideline-concordant care, a score of 1 indicates implicit discouragement (e.g., emphasizing the side effects of AEDs without balanced information about the risks of untreated epilepsy), and a score of 2 indicates explicit discouragement of evidence-based care (e.g., advising viewers to stop prescribed medications or avoid neurology consultations). For statistical analysis, the mean TMRS score per video was calculated (total raw score ÷ 3 items), yielding a normalized final score range of 0–2, with risk stratification thresholds established via equal tertile division of the 0–2 normalized scale, a pragmatic approach consistent with validated health misinformation risk scales in the existing literature27. Scores of 0–0.67 indicate low misinformation risk, corresponding to a raw total score of 0–2, meaning no items scored 2 (high risk) and at most 2 items scored 1 (moderate risk), with no clearly inaccurate or dangerous treatment claims; scores of 0.68–1.33 indicate moderate misinformation risk, corresponding to a raw total score of 2–4, meaning content contains partially misleading claims or implicit discouragement of evidence-based care, but no single item scored 2 (i.e., no explicit high-risk misinformation); scores of 1.34–2.00 indicate high misinformation risk, corresponding to a raw total score of 4–6, meaning content contains at least one item scored 2 (clear, clinically significant high-risk misinformation) or multiple moderate-risk items that cumulatively pose substantial potential for patient harm, directly linking the single-item high-risk score of 2 to the high-risk stratification threshold. All TMRS scores reported in the results are normalized mean scores (0–2), and we acknowledge that the TMRS has not yet been externally validated in independent study samples, with its thresholds interpreted as exploratory rather than definitive, and future studies are warranted to establish the external validity and predictive utility of this instrument[21,22,23].
What the sources say
- Not checked — no full text of the sourcecites [3] Beghi, E. The epidemiology of epilepsy. Neuroepidemiology 54, 185–191 (2020). source
- Supportedcites [7] Scheffer, I. E. et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58, 512–521 (2017). source
The Introduction identifies epilepsy classification as a clinical tool and says it often guides the selection of antiepileptic therapies. The Classification of the Epilepsies section also sets out etiological categories with treatment implications. This source supports the classification component of the cited clinical basis; the sentence does not attribute the scale’s development or the social-media misinformation literature specifically to this paper. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [8] Trinka, E. et al. A definition and classification of status epilepticus. Epilepsia 56, 1515–1523 (2015). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“TMRS scores were positively correlated with likes (rho = 0.46, P < 0.001), shares (rho = 0.43, P < 0.001), and comments (rho = 0.39, P < 0.001), while quality scores showed no significant”
§ Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis > Abstract Epilepsy is one of the most prevalent chronic neurological disorders worldwide, affecting approximately 70 million people globally and imposing substantial burdens on patients, families, and healthcare systems. Its multifaceted treatment landscape spanning antiepileptic drug (AED) therapy, epilepsy surgery, ketogenic dietary therapy, and neuromodulation makes accurate health information critical for patient decision-making and treatment adherence. Short-video platforms such as TikTok (Douyin) and Bilibili have emerged as primary channels through which the public accesses health-related content, yet the quality and reliability of epilepsy-related content on these platforms remain largely unexamined. A cross-sectional content analysis was conducted. We systematically retrieved videos via keyword search on TikTok (Douyin) and Bilibili, using the terms “dianxian” (epilepsy) and “jingfeng” (seizure/convulsion). For each platform, we collected the top 100 unique videos ranked by the platform’s default relevance algorithm, with duplicate results from the two search terms removed. After applying pre-specified inclusion and exclusion criteria, 182 videos were included in the final analysis. Two physicians independently assessed the videos using a multi-instrument framework with clear applicable boundaries: Global Quality Score (GQS, for overall educational quality across all content types), modified DISCERN (mDISCERN, exclusively for treatment information reliability), JAMA benchmark criteria (for source transparency, not direct clinical accuracy), and a novel Treatment Misinformation Risk Scale (TMRS, specifically for epilepsy treatment-related content). Inter-rater reliability was assessed using the intraclass correlation coefficient (ICC). Engagement metrics and uploader characteristics were also recorded, with sensitivity analyses performed to control for confounding from uneven content theme distribution between platforms. A total of 182 videos were analyzed (96 from TikTok, 86 from Bilibili). The overall educational quality was suboptimal (mean GQS: 2.65 ± 0.93; mDISCERN: 2.12 ± 0.89 for treatment-containing videos). Bilibili videos demonstrated significantly higher performance across all instruments: overall educational quality (GQS: 3.11 ± 0.87 vs. 2.24 ± 0.84, P < 0.001), treatment information reliability (mDISCERN: 2.56 ± 0.81 vs. 1.74 ± 0.76, P < 0.001), and source transparency (JAMA: 2.18 ± 0.72 vs. 1.42 ± 0.68, P < 0.001). The mean normalized TMRS score was 1.15 ± 0.62, with TikTok showing significantly higher treatment misinformation risk (1.41 ± 0.54) than Bilibili (0.86 ± 0.53, P < 0.001). TMRS scores were positively correlated with likes (rho = 0.46, P < 0.001), shares (rho = 0.43, P < 0.001), and comments (rho = 0.39, P < 0.001), while quality scores showed no significant correlation with engagement. Sensitivity analyses confirmed that the observed platform differences were not confounded by differences in content theme distribution. Epilepsy-related content on China’s major short-video platforms is of concerningly poor quality, with treatment misinformation receiving disproportionately higher user engagement. These findings highlight the urgent need for collaborative efforts among neurologists, platform operators, and health authorities to improve the quality of epilepsy health information in the digital environment.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The overall educational quality was suboptimal (mean GQS: 2.65 ± 0.93; mDISCERN: 2.12 ± 0.89 for treatment-containing videos).”
§ Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis > Abstract Epilepsy is one of the most prevalent chronic neurological disorders worldwide, affecting approximately 70 million people globally and imposing substantial burdens on patients, families, and healthcare systems. Its multifaceted treatment landscape spanning antiepileptic drug (AED) therapy, epilepsy surgery, ketogenic dietary therapy, and neuromodulation makes accurate health information critical for patient decision-making and treatment adherence. Short-video platforms such as TikTok (Douyin) and Bilibili have emerged as primary channels through which the public accesses health-related content, yet the quality and reliability of epilepsy-related content on these platforms remain largely unexamined. A cross-sectional content analysis was conducted. We systematically retrieved videos via keyword search on TikTok (Douyin) and Bilibili, using the terms “dianxian” (epilepsy) and “jingfeng” (seizure/convulsion). For each platform, we collected the top 100 unique videos ranked by the platform’s default relevance algorithm, with duplicate results from the two search terms removed. After applying pre-specified inclusion and exclusion criteria, 182 videos were included in the final analysis. Two physicians independently assessed the videos using a multi-instrument framework with clear applicable boundaries: Global Quality Score (GQS, for overall educational quality across all content types), modified DISCERN (mDISCERN, exclusively for treatment information reliability), JAMA benchmark criteria (for source transparency, not direct clinical accuracy), and a novel Treatment Misinformation Risk Scale (TMRS, specifically for epilepsy treatment-related content). Inter-rater reliability was assessed using the intraclass correlation coefficient (ICC). Engagement metrics and uploader characteristics were also recorded, with sensitivity analyses performed to control for confounding from uneven content theme distribution between platforms. A total of 182 videos were analyzed (96 from TikTok, 86 from Bilibili). The overall educational quality was suboptimal (mean GQS: 2.65 ± 0.93; mDISCERN: 2.12 ± 0.89 for treatment-containing videos). Bilibili videos demonstrated significantly higher performance across all instruments: overall educational quality (GQS: 3.11 ± 0.87 vs. 2.24 ± 0.84, P < 0.001), treatment information reliability (mDISCERN: 2.56 ± 0.81 vs. 1.74 ± 0.76, P < 0.001), and source transparency (JAMA: 2.18 ± 0.72 vs. 1.42 ± 0.68, P < 0.001). The mean normalized TMRS score was 1.15 ± 0.62, with TikTok showing significantly higher treatment misinformation risk (1.41 ± 0.54) than Bilibili (0.86 ± 0.53, P < 0.001). TMRS scores were positively correlated with likes (rho = 0.46, P < 0.001), shares (rho = 0.43, P < 0.001), and comments (rho = 0.39, P < 0.001), while quality scores showed no significant correlation with engagement. Sensitivity analyses confirmed that the observed platform differences were not confounded by differences in content theme distribution. Epilepsy-related content on China’s major short-video platforms is of concerningly poor quality, with treatment misinformation receiving disproportionately higher user engagement. These findings highlight the urgent need for collaborative efforts among neurologists, platform operators, and health authorities to improve the quality of epilepsy health information in the digital environment.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
51 more claims
Create a free account to see all 122 claims and every source verdict.
- It may state two separate claims as one. 45
- Probably not a substantial claim. 36
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis > Methods > Statistical analysis
“Due to the non-normal distribution of the data, as confirmed by the Shapiro–Wilk test (all P < 0.05), non-parametric statistical methods were employed throughout.”
§ Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis > Methods > Statistical analysis
“Subgroup analyses stratified by content theme and uploader category were performed using independent-samples t-tests or Mann–Whitney U tests as appropriate.”
Citations
Cites
ILAE official report: a practical clinical definition of epilepsy
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., et al. (2014) · Epilepsia · doi:10.1111/epi.12550 · Cited by 6,108
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054 · cited 1×
“…treatment information, with the scale developed based on established epilepsy clinical evidence, classification criteria, and treatment guidelines 3,7,8,31,32 as well as emerging literature on health misinformation on social media, and reviewed by two senior neurologists with specialized expertise…”
Self-citationFisher, R. S., Cross, J. H., French, J. A., Higurashi, N., Hirsch, E., Jansen, F. E., Lagae, L., Moshé, S. L., Peltola, J., Roulet Perez, E., et al. (2017) · Epilepsia · doi:10.1111/epi.13670 · Cited by 3,483
Charnock, D., Shepperd, S., Needham, G., & Gann, R. (1999) · Journal of Epidemiology and Community Health · doi:10.1136/jech.53.2.105 · Cited by 3,329 · cited 1×
“…from the original DISCERN questionnaire—the gold-standard tool for evaluating the reliability of consumer health information on treatment choices 25 —was optimized for short-form video content in this study, using a 1–5 Likert scale to assess the reliability of treatment-related information,…”
Trinka, E., Cock, H., Hesdorffer, D., Rossetti, A. O., Scheffer, I. E., Shinnar, S., Shorvon, S., & Lowenstein, D. H. (2015) · Epilepsia · doi:10.1111/epi.13121 · Cited by 2,494 · cited 2×
“…information, with the scale developed based on established epilepsy clinical evidence, classification criteria, and treatment guidelines 3,7,8,31,32 as well as emerging literature on health misinformation on social media, and reviewed by two senior neurologists with specialized expertise…”
Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies
Fiest, K. M., Sauro, K. M., Wiebe, S., Patten, S. B., Kwon, C.-S., Dykeman, J., Pringsheim, T., Lorenzetti, D. L., & Jetté, N. (2017) · Neurology · doi:10.1212/wnl.0000000000003509 · Cited by 1,902
Systematic Literature Review on the Spread of Health-related Misinformation on Social Media
Wang, Y., McKee, M., Torbica, A., & Stuckler, D. (2019) · Social Science & Medicine · doi:10.1016/j.socscimed.2019.112552 · Cited by 1,806
Self-citationPrevalence of health misinformation on social media: systematic review
Suarez-Lledo, V., & Alvarez-Galvez, J. (2021) · Journal of Medical Internet Research · doi:10.2196/17187 · Cited by 1,564
Beghi, E. (2020) · Neuroepidemiology · doi:10.1159/000503831 · Cited by 1,452
Cited by
Pan, S., Wang, L., Zhang, J., Chi, T., Ma, P., Zhao, W., Xu, D., & Jiao, L. (2026) · Research Square · doi:10.21203/rs.3.rs-10217883/v1
Li, Y., An, C., Feng, J., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10797853/v1
Metadata
- Authors
- Zhang, Y.-J., Guo, Y.-Y., & Wang, Y.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Guo, Yue-ying
- Wang, Yong
- Venue
- Scientific Reports
- Published
- 2026-05-08
- Volume
- 16
- Issue
- 1
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC13341740
- OpenAlex
- W7160634592
- Cited by
- 3
- References
- 39
- Citations by year
- 2026: 3
- FWCI
- 21.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor, 61 d)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Social Sciences › Health › Social Media in Health Education
- Health Sciences › Health Professions › General Health Professions › Health Literacy and Information Accessibility
- Social Sciences › Sociology and Political Science › Misinformation and Its Impacts
- Keywords
- epilepsy, health misinformation, short video platforms, Bilibili, online health information quality, antiepileptic drugs, ketogenic diet, epilepsy surgery, neuromodulation, DISCERN, source transparency, user engagement metrics, social media health education
- MeSH terms
- Digital Media, China, Communication, Cross-Sectional Studies, Epilepsy, Humans, Video Recording, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis. https://app.cochat.ai/papers/10.1038/s41598-026-52532-5
- The paper
- Zhang, Y.-J., Guo, Y.-Y., & Wang, Y. (2026). Quality, reliability, and treatment misinformation risk of epilepsy content on Chinese short-video platforms TikTok (Douyin) and Bilibili: a cross-sectional analysis. Scientific Reports. https://doi.org/10.1038/s41598-026-52532-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
